5um Streptavidin Magnetic Beads MSA5UM-10 1%

5µm Streptavidin Magnetic Beads MSA5UM-10

MSA5UM-10 is a 5µm streptavidin-functional magnetic bead suspension supplied at 1% solids.

When the solids concentration is expressed as weight per volume, 1% corresponds to approximately 10mg of magnetic beads per milliliter of suspension.

The product is developed for the capture and immobilization of biotinylated antibodies, antigens, proteins, peptides, aptamers, oligonucleotides and other biotin-labelled biomolecules.

MSA5UM-10 can be evaluated as a magnetic solid phase in chemiluminescence immunoassay development, magnetic immunoassay research, biomolecule enrichment, sample preparation, process scale-up and batch reagent manufacturing.

Streptavidin immobilized on the magnetic bead surface binds biotinylated ligands without requiring the end user to activate the beads with EDC, NHS, glutaraldehyde or another chemical activation reagent.

After loading a selected biotinylated capture molecule, the functionalized magnetic beads can be used for target capture, magnetic collection, repeated washing and downstream signal detection.

MSA5UM-10 is intended for biotechnology companies, immunoassay developers, research institutions and reagent manufacturers requiring a defined 5µm streptavidin magnetic bead raw material for laboratory evaluation, pilot production and bulk supply.

The finished reagent should be validated using the intended biotinylated ligand, sample matrix, magnetic separator, washing program, detection chemistry and immunoassay analyzer.

Product Overview

The streptavidin–biotin system provides a flexible method for immobilizing different biotinylated biomolecules on a common magnetic solid phase.

Commercial exact-5µm streptavidin magnetic beads are used for capturing biotinylated antibodies, antigens, proteins and nucleic acid probes. They are also marketed for immunoassays, magnetic particle chemiluminescence, protein isolation, nucleic acid capture and cell separation.

MSA5UM-10 is designed to support:

• Biotinylated antibody immobilization;

• Biotinylated antigen immobilization;

• Magnetic sandwich immunoassays;

• Antibody-detection assays;

• Competitive immunoassays;

• Chemiluminescence immunoassay development;

• Electrochemiluminescence assay research;

• Immunomagnetic enrichment;

• Biotinylated peptide capture;

• Nucleic acid and aptamer capture;

• Automated reagent development;

• Pilot-scale manufacturing;

• Batch production.

MSA5UM-10 is supplied as a research and reagent-development raw material. It is not supplied as a finished diagnostic reagent.

MSA5UM-10 Product Specifications

The following product-specific parameters should be confirmed through the applicable technical data sheet and lot-specific certificate of analysis:

• Particle-size distribution;

• Streptavidin loading;

• Streptavidin activity;

• Free biotin-binding capacity;

• Biotinylated antibody-loading capacity;

• Biotinylated oligonucleotide-loading capacity;

• Nonspecific binding;

• Magnetic collection performance;

• Suspension buffer;

• Blocking formulation;

• Preservative system;

• Storage conditions;

• Shelf life;

• Lot-release criteria.

Commercial suppliers use different particle structures, surface chemistries and analytical methods. Competitor binding-capacity values should therefore be used only for market benchmarking, not as specifications for MSA5UM-10.

How Do Streptavidin Magnetic Beads Work?

Streptavidin immobilized on the magnetic bead surface provides affinity-binding sites for biotin.

When a biotinylated antibody, antigen, protein, peptide or oligonucleotide is incubated with MSA5UM-10, the biotin group binds to streptavidin on the bead surface.

The resulting complex can be represented as:

Magnetic bead–streptavidin–biotin–ligand

The biotinylated ligand provides biological target recognition, while the magnetic particle provides a solid phase for collection, washing and reagent handling.

Commercial streptavidin-coated magnetic particles are used to bind biotinylated antibodies, proteins, nucleic acid probes and other labelled biomolecules in immunoassay and separation workflows.

Example Using a Biotinylated Capture Antibody

A magnetic sandwich immunoassay may include the following steps:

1. Prepare a biotinylated capture antibody.

2. Incubate the antibody with MSA5UM-10.

3. Allow biotin to bind to surface streptavidin.

4. Magnetically collect the antibody-loaded beads.

5. Remove unbound antibody.

6. Resuspend the loaded beads in the selected formulation.

7. Incubate the beads with the sample.

8. Capture the target antigen.

9. Add a labelled detection antibody.

10. Magnetically collect and wash the immune complex.

11. Add or trigger the chemiluminescent signal reagent.

12. Measure the analytical signal.

Example Using a Biotinylated Antigen

For an antibody-detection assay:

1. Prepare a biotinylated antigen.

2. Load the antigen onto MSA5UM-10.

3. Remove unbound antigen.

4. Incubate the antigen-loaded beads with the sample.

5. Capture target-specific antibodies.

6. Add a labelled secondary antibody.

7. Perform magnetic collection and washing.

8. Measure the resulting signal.

Example Using a Biotinylated Oligonucleotide

A biotinylated oligonucleotide may be immobilized for:

• Nucleic acid capture;

• Hybridization assays;

• Aptamer-based detection;

• Target enrichment;

• Probe immobilization;

• Molecular diagnostic research;

• Pull-down experiments;

• Sample preparation before amplification.

The position and degree of biotinylation should be selected to preserve hybridization or target-recognition activity.

Key Features of MSA5UM-10

Defined 5µm Particle Size

MSA5UM-10 provides a defined 5µm magnetic particle format rather than a broad micrometer-scale range.

Particle size can influence:

• Particle number per unit mass;

• Geometric surface area;

• Ligand accessibility;

• Gravity-driven settling;

• Magnetic collection;

• Collection-zone formation;

• Washing efficiency;

• Redispersion;

• Automated liquid handling.

Actual performance also depends on magnetic material content, particle-size distribution, surface coating, streptavidin density, suspension buffer and magnet configuration.

Streptavidin-Functional Surface

The bead surface provides affinity-binding sites for biotinylated ligands.

Potential ligands include:

• Biotinylated monoclonal antibodies;

• Biotinylated polyclonal antibodies;

• Biotinylated recombinant antigens;

• Biotinylated natural proteins;

• Biotinylated peptides;

• Biotinylated enzymes;

• Biotinylated aptamers;

• Biotinylated DNA probes;

• Biotinylated RNA probes;

• Biotinylated haptens;

• Other biotin-labelled affinity molecules.

1% Solids Formulation

When expressed as w/v, a 1% solids suspension corresponds to approximately 10mg/mL.

Approximate bead-mass calculations are:

• 10µL contains approximately 0.1mg of beads;

• 50µL contains approximately 0.5mg of beads;

• 100µL contains approximately 1mg of beads;

• 500µL contains approximately 5mg of beads;

• 1mL contains approximately 10mg of beads.

These calculations should only be used after confirming that the 1% specification is expressed as w/v.

Exact-5µm competitors are also supplied at 10mg/mL or 1% solids, making this a familiar concentration for competitive comparison and method development.

No Additional Bead Activation Required

A properly biotinylated ligand can normally be loaded without activating the magnetic bead surface using EDC/NHS or another covalent coupling reagent.

This can simplify assay development because different biotinylated capture molecules can be compared using the same magnetic bead platform.

Flexible Ligand Screening

MSA5UM-10 can be evaluated with multiple biotinylated antibodies, antigens or probes.

This supports:

• Capture-antibody screening;

• Antibody-pair comparison;

• Antigen-construct evaluation;

• Peptide screening;

• Aptamer screening;

• Assay-target expansion;

• Multiproduct reagent development.

Magnetic Solid-Phase Processing

After ligand loading and target capture, the particles can be collected using a compatible magnetic separator.

A typical process includes:

• Bead dispensing;

• Sample incubation;

• Target capture;

• Magnetic collection;

• Supernatant removal;

• Washing;

• Detection-reagent incubation;

• Additional magnetic washing;

• Signal generation.

Research-to-Production Supply

MSA5UM-10 can support:

• Initial feasibility evaluation;

• Biotinylated ligand screening;

• Immunoassay optimization;

• Automated-analyzer evaluation;

• Stability studies;

• Pilot manufacturing;

• Lot-consistency assessment;

• Bulk raw-material procurement.

Why Choose 5µm Streptavidin Magnetic Beads?

Exact 5µm Product Positioning

Some suppliers offer 4.0–4.5µm or 4.5µm products, while others provide an exact nominal 5µm specification. MSA5UM-10 is positioned for customers whose development project, raw-material specification or instrument evaluation requires a defined 5µm streptavidin bead.

Clearly Observable Magnetic Collection

Under a compatible magnetic field, 5µm particles may form a more clearly observable collection zone than smaller beads.

This may help researchers monitor:

• Whether bead collection is complete;

• Whether particles are lost during aspiration;

• Whether aggregation has occurred;

• Whether washing is consistent;

• Whether the collected particles are completely redispersed.

Actual magnetic collection depends on the magnetic material content, bead concentration, magnet strength, vessel geometry, buffer viscosity and sample volume.

Practical Repeated Washing

Chemiluminescence immunoassays commonly require several magnetic collection and washing cycles.

MSA5UM-10 may be evaluated for workflows requiring:

• Repeatable magnetic recovery;

• Controlled supernatant removal;

• Low bead loss;

• Consistent washing;

• Complete bead redispersion;

• Stable residual volume;

• Repeatable analytical precision.

Suitable for Manual and Automated Development

The visible collection characteristics of larger micrometer-scale beads may be useful during manual development and troubleshooting.

MSA5UM-10 may also be evaluated with automated analyzers, but compatibility must be validated for the specific system.

Important parameters include:

• Reagent-reservoir mixing;

• Bead-dispensing accuracy;

• Pipette-tip dimensions;

• Tubing dimensions;

• Reaction-cup geometry;

• Magnet position;

• Magnetic collection time;

• Aspiration height;

• Wash volume;

• Bead redispersion;

• Carryover.

TargetMol and BeaverBio both position their 5µm streptavidin products for immunoassay or automated high-throughput applications, but actual compatibility remains instrument-specific.

Important Surface-Area Tradeoff

Compared with smaller particles of similar composition and density, 5µm beads generally provide fewer particles and less geometric surface area per unit mass.

Therefore, a protocol developed using 1µm beads should not be transferred directly to 5µm beads without re-optimizing:

• Bead dosage;

• Ligand-to-bead ratio;

• Loading time;

• Mixing;

• Sample-incubation time;

• Washing;

• Final bead concentration.

The best particle size should be selected according to functional assay performance rather than nominal diameter alone.

5µm vs 3µm, 2.8µm and 1µm Streptavidin Beads

Differences in surface chemistry, particle-size distribution, magnetic loading, streptavidin density, blocking formulation and suspension buffer may be more important than a small difference in nominal diameter.

A side-by-side comparison should evaluate:

• Biotinylated antibody loading;

• Target-capture efficiency;

• Blank signal;

• Positive signal;

• Signal-to-background ratio;

• Magnetic recovery;

• Washing efficiency;

• Redispersion;

• Precision;

• Stability;

• Instrument compatibility.

Applications in Chemiluminescence Immunoassays

Magnetic Sandwich Immunoassays

A biotinylated capture antibody can be loaded onto MSA5UM-10.

The antibody-loaded particles capture the target antigen from the sample. A labelled detection antibody then forms a sandwich immune complex.

After magnetic collection and washing, the detection label generates the chemiluminescent signal.

Important development variables include:

• Bead dosage;

• Capture-antibody loading;

• Degree of antibody biotinylation;

• Sample volume;

• Capture time;

• Detection-antibody concentration;

• Wash efficiency;

• Chemiluminescent substrate;

• Signal-to-background ratio.

Direct Chemiluminescence Assays

MSA5UM-10 may be evaluated in direct chemiluminescence systems using a suitable biotinylated ligand and signal-labelled recognition reagent.

Commercial exact-5µm streptavidin beads are specifically positioned for magnetic particle-based chemiluminescence and neutralizing-antibody detection.

Performance of MSA5UM-10 must be validated independently in the complete reagent system.

Indirect Chemiluminescence Assays

The particles may be evaluated with:

• Biotinylated secondary antibodies;

• Biotinylated anti-species antibodies;

• Biotinylated affinity proteins;

• Biotinylated peptides;

• Biotinylated aptamers.

Electrochemiluminescence Assay Research

MSA5UM-10 may be evaluated in electrochemiluminescence immunoassay research.

Compatibility should be confirmed with:

• Magnetic positioning module;

• Electrode configuration;

• Electrochemiluminescent label;

• Reaction buffer;

• Reaction vessel;

• Fluidic system;

• Washing sequence;

• Signal-reading program.

Antibody-Detection Assays

A biotinylated antigen can be immobilized on MSA5UM-10 to capture target antibodies from research samples.

Potential applications include:

• Infectious-disease antibody research;

• Autoantibody assays;

• Vaccine-response studies;

• Recombinant antigen evaluation;

• Antibody-response monitoring.

Competitive Immunoassays

Biotinylated antigens, haptens or small-molecule conjugates may be immobilized for competitive immunoassay development.

This format may be evaluated when the target analyte cannot support a conventional two-antibody sandwich structure.

Immunomagnetic Enrichment

Biotinylated affinity ligands loaded onto MSA5UM-10 can be evaluated for enrichment of:

• Proteins;

• Antigens;

• Cells;

• Microorganisms;

• Biological particles;

• Other affinity-recognized targets.

Nucleic Acid and Aptamer Capture

Biotinylated DNA, RNA or aptamer probes may be immobilized for:

• Hybridization assays;

• Nucleic acid enrichment;

• Target capture before amplification;

• Aptamer-based detection;

• Biosensor development;

• Molecular diagnostic research;

• DNA–protein interaction studies.

Commercial 5µm streptavidin products are marketed for biotinylated nucleic acid probes, DNA–protein interaction studies and magnetic separation of biomolecules.

Compatible Biotinylated Antibodies and Biomolecules

Biotinylated Antibodies

Important antibody variables include:

• Antibody purity;

• Antibody concentration;

• Biotinylation chemistry;

• Degree of biotinylation;

• Biotin position;

• Antibody aggregation;

• Retained antigen-binding activity;

• Original formulation buffer.

Excessive biotinylation may reduce biological activity or produce an unfavourable orientation on the magnetic bead surface.

Insufficient biotinylation may reduce bead loading and target capture.

Biotinylated Antigens

Biotinylated antigens may be used for antibody-detection assays.

The developer should confirm that biotinylation does not modify or block a critical antigenic epitope.

Biotinylated Peptides

Potential applications include:

• Antibody screening;

• Epitope analysis;

• Competitive immunoassays;

• Protein-interaction research;

• Affinity capture.

Biotinylated Oligonucleotides

Biotin may be introduced at the 5′ end, 3′ end or another validated position.

The modification position should preserve hybridization, target recognition or aptamer activity after immobilization.

Biotinylated Proteins and Enzymes

Biotinylated recombinant proteins or enzymes may be evaluated for:

• Protein-interaction studies;

• Enzyme assays;

• Affinity enrichment;

• Biosensor development;

• Calibration-material preparation.

Recommended Biotinylated Ligand Loading Workflow

The following workflow is a general development framework. It is not a validated product-specific protocol.

Step 1: Characterize the Biotinylated Ligand

Record:

• Ligand identity;

• Molecular weight;

• Concentration;

• Purity;

• Original formulation;

• Biotinylation method;

• Estimated degree of biotinylation;

• Biological activity;

• Aggregation status;

• Stabilizing additives.

Step 2: Remove Excess Free Biotin

Free biotin can occupy available streptavidin-binding sites and reduce loading of the intended biotinylated antibody, antigen, protein or oligonucleotide.

Potential purification methods include:

• Desalting;

• Dialysis;

• Size-exclusion chromatography;

• Ultrafiltration;

• HPLC or FPLC where appropriate;

• Another validated purification method.

Step 3: Fully Resuspend MSA5UM-10

Mix the original suspension until homogeneous before sampling.

Possible methods include:

• Gentle inversion;

• Roller mixing;

• End-over-end rotation;

• Controlled vortexing;

• Another validated mixing method.

Because 5µm particles may settle more noticeably than smaller beads, maintain appropriate mixing when preparing multiple aliquots.

Avoid excessive foaming.

Step 4: Calculate the Required Bead Mass

Assuming a concentration of 10mg/mL:

Bead mass = suspension volume × 10mg/mL

Prepare multiple bead-dose groups rather than testing only one condition.

Step 5: Wash or Equilibrate the Beads

Collect the particles using a compatible magnetic separator.

Remove the original suspension medium when required and equilibrate the beads in a validated ligand-loading buffer.

Do not allow the magnetic beads to dry.

Step 6: Add the Biotinylated Ligand

Evaluate several ligand-to-bead ratios.

Possible experimental groups include:

• Low ligand loading;

• Medium ligand loading;

• High ligand loading;

• Different incubation times;

• Different temperatures;

• Different buffer formulations.

Step 7: Maintain Gentle Mixing

Use sufficient mixing to maintain uniform bead–ligand contact without damaging the biological ligand.

For 5µm beads, mixing should be sufficient to prevent uneven settling during the loading reaction.

Step 8: Magnetically Collect the Loaded Beads

Standardize:

• Magnet type;

• Vessel;

• Reaction volume;

• Bead concentration;

• Collection time;

• Collection position;

• Residual liquid volume.

Step 9: Retain the Supernatant

Retain the post-loading supernatant when ligand-loading efficiency needs to be measured.

Step 10: Wash the Loaded Beads

Remove:

• Unbound biotinylated ligand;

• Residual free biotin;

• Unwanted formulation components;

• Other unbound materials.

Step 11: Resuspend in the Final Buffer

Potential formulation components include:

• Buffer;

• Salt;

• Protein stabilizer;

• Synthetic polymer;

• Surfactant;

• Preservative;

• Sugar or polyol;

• Blocking component.

Step 12: Evaluate Functional Performance

Recommended tests include:

• Ligand-loading efficiency;

• Target-capture capacity;

• Blank signal;

• Positive signal;

• Signal-to-background ratio;

• Magnetic recovery;

• Bead redispersion;

• Precision;

• Accelerated stability;

• Real-time stability.

How to Optimize MSA5UM-10 in an Immunoassay

Optimize Bead Dosage

Compare several bead quantities in the complete assay.

Too few beads may limit target capture.

Too many beads may increase:

• Reagent consumption;

• Blank signal;

• Nonspecific adsorption;

• Washing requirements;

• Residual bead interference;

• Instrument carryover.

Optimize Biotinylated Ligand Loading

Evaluate several quantities of biotinylated antibody or antigen per milligram of magnetic beads.

The highest ligand-loading condition is not necessarily the best analytical condition.

Excessive loading may cause:

• Steric crowding;

• Reduced target accessibility;

• Higher nonspecific binding;

• Reduced functional activity;

• Poorer storage stability.

Optimize the Degree of Biotinylation

Compare ligands with different biotinylation levels.

Evaluate:

• Bead-loading efficiency;

• Retained biological activity;

• Target-capture performance;

• Blank signal;

• Positive signal;

• Precision;

• Stability.

Optimize Mixing

Because 5µm particles can settle during incubation, evaluate:

• Continuous versus intermittent mixing;

• Rotation speed;

• Shaking speed;

• Mixing duration;

• Reaction-vessel geometry;

• Bead uniformity;

• Foam formation;

• Ligand stability.

Optimize Magnetic Separation

Evaluate:

• Magnet strength;

• Magnet position;

• Collection time;

• Reaction-vessel geometry;

• Bead concentration;

• Buffer viscosity;

• Residual liquid;

• Bead loss during aspiration.

Optimize Washing

Compare:

• Wash-buffer composition;

• Surfactant concentration;

• Wash volume;

• Number of wash cycles;

• Mixing during washing;

• Magnetic collection time;

• Residual wash volume.

Insufficient washing may increase background. Excessive or aggressive washing may reduce bead recovery or affect sensitive assay components.

Optimize Blocking and Storage Formulation

Potential formulation variables include:

• Protein blockers;

• Synthetic blocking polymers;

• Nonionic surfactants;

• Ionic strength;

• Sugars;

• Polyols;

• Preservatives.

The final formulation should support bead dispersion, low background, streptavidin activity and ligand stability.

Optimize Automated Analyzer Parameters

For automated CLIA development, evaluate:

• Reagent-reservoir mixing frequency;

• Bead-dispensing accuracy;

• Settling during standby;

• Incubation mixing;

• Magnetic collection time;

• Aspiration height;

• Wash cycles;

• Residual volume;

• Bead redispersion;

• Carryover.

How to Evaluate Biotin-Binding Performance

Total Biotin-Binding Capacity

A labelled biotin reagent can be used to estimate the available streptavidin-binding sites.

Suppliers use different test molecules and methods. For example, exact-5µm competitors separately report capacity for short biotinylated nucleic acid probes and Biotin-IgG, while other suppliers report free-biotin capacity in pmol per milligram.

MSA5UM-10 should have its own validated test method and internal acceptance range.

Biotinylated Antibody Loading

Measure the antibody quantity before and after loading.

An approximate calculation is:

Loaded antibody = Initial antibody − Unbound antibody

Possible analytical methods include:

• UV absorbance;

• BCA assay;

• Bradford assay;

• Fluorescence measurement;

• ELISA;

• Another validated protein assay.

Functional Target-Capture Capacity

Chemical loading does not confirm that the antibody or antigen remains biologically active.

Functional testing should measure actual target capture under representative assay conditions.

Nonspecific Binding

Compare:

• Unloaded streptavidin beads;

• Ligand-loaded beads;

• Blocked beads;

• Negative samples;

• Positive samples;

• Representative interfering materials.

Magnetic Recovery

Measure bead recovery after repeated magnetic collection and washing.

Immunoassay Performance

Evaluate:

• Blank signal;

• Negative-sample signal;

• Low-positive signal;

• High-positive signal;

• Signal-to-background ratio;

• Precision;

• Recovery;

• Linearity;

• Specificity;

• Hook effect;

• Stability.

Quality Control for Research and Batch Production

Appearance and Dispersion

Inspect:

• Suspension appearance;

• Visible aggregation;

• Sedimentation behaviour;

• Homogeneity after mixing;

• Ease of redispersion;

• Stability during processing holds.

Particle Size and Distribution

Confirm the nominal 5µm particle size using an appropriate validated method.

For batch manufacturing, monitor both average particle size and particle-size distribution.

Solids Content

Verify solids concentration because it affects:

• Bead-mass calculations;

• Ligand-loading calculations;

• Assay formulation;

• Filling accuracy;

• Production yield.

Streptavidin Activity

Use a standardized biotin-binding test to evaluate functional streptavidin activity on the bead surface.

Biotin-Binding Capacity

Establish a validated test method and internal acceptance range.

Competitor values should only be used as benchmarking information, not as specifications for MSA5UM-10.

Biotinylated Antibody Loading

Use a representative biotinylated antibody to evaluate practical ligand-loading performance.

Magnetic Collection Performance

Standardize:

• Magnet;

• Vessel;

• Sample volume;

• Buffer;

• Bead concentration;

• Temperature;

• Collection time.

Nonspecific Binding

Evaluate background using representative proteins, antibodies and sample matrices.

Functional Immunoassay Performance

Recommended tests include:

• Blank signal;

• Negative-sample signal;

• Positive-sample signal;

• Signal-to-background ratio;

• Analytical sensitivity;

• Precision;

• Recovery;

• Linearity;

• Specificity;

• Stability.

Lot-to-Lot Consistency

For routine manufacturing, establish acceptance ranges for:

• Particle size;

• Particle-size distribution;

• Solids content;

• Streptavidin activity;

• Biotin-binding capacity;

• Magnetic collection;

• Dispersion;

• Nonspecific binding;

• Functional immunoassay performance.

Final raw-material approval should be based on performance in the complete assay system.

Scale-Up and Bulk Supply for Immunoassay Manufacturers

Evaluation Stage

Evaluation samples can support screening of:

• Biotinylated capture antibodies;

• Biotinylated antigens;

• Bead dosage;

• Ligand-loading level;

• Blocking formulation;

• Magnetic separation;

• Assay sensitivity;

• Background signal.

Pilot-Scale Stage

Pilot quantities can support:

• Ligand-loading process confirmation;

• Reagent formulation;

• Analyzer compatibility testing;

• Stability studies;

• Filling-process evaluation;

• Initial lot-consistency testing.

Batch-Production Stage

Bulk-supply planning may include:

• Annual demand;

• Purchasing forecast;

• Packaging volume;

• Quality specifications;

• Technical documentation;

• Quality documentation;

• Reserved-lot requirements;

• Change-control expectations;

• Safety-stock planning.

Exact-5µm competitors offer 1mL, multiple-vial, 5mL or 10mL formats, while some suppliers also provide bulk-quotation channels. This shows that scalable packaging and long-term supply are important purchasing requirements in this product category.

Scale-Up Considerations

A laboratory ligand-loading procedure should not be scaled only by multiplying reagent volumes.

Revalidate:

• Vessel geometry;

• Mixing efficiency;

• Bead homogeneity;

• Ligand-addition sequence;

• Incubation time;

• Temperature uniformity;

• Magnetic collection;

• Washing efficiency;

• Process hold time;

• Final filling uniformity.

For 5µm particles, maintaining a homogeneous suspension during loading and filling is especially important.

Custom Streptavidin Magnetic Bead Services

SHBC can evaluate customized streptavidin magnetic bead requirements for biotechnology companies, research institutions and immunoassay manufacturers.

Potential customization options include:

• Alternative particle sizes;

• Customized solids content;

• Adjusted streptavidin loading;

• Customer-specific biotin-binding targets;

• Alternative blocking systems;

• Customized suspension buffer;

• Alternative preservative systems;

• Customer-specified pH;

• Special packaging volumes;

• Pilot-scale manufacturing;

• Bulk manufacturing;

• OEM packaging;

• Private-label services;

• Customer-specific quality testing.

Customization feasibility depends on the requested specifications, intended application, validation requirements and order quantity.

Storage and Handling Recommendations

Store MSA5UM-10 according to the product label, technical data sheet and lot-specific certificate of analysis.

General handling recommendations include:

• Mix thoroughly before sampling;

• Maintain suspension uniformity during dispensing;

• Use clean and calibrated equipment;

• Avoid allowing the magnetic beads to dry;

• Prevent microbial and chemical contamination;

• Avoid freezing unless specifically validated;

• Avoid unnecessary exposure to extreme temperatures;

• Confirm buffer compatibility before buffer exchange;

• Prevent contamination with free biotin;

• Record the product lot number;

• Evaluate ligand-loaded bead stability separately.

Commercial 5µm streptavidin bead instructions commonly recommend thorough mixing before sampling, avoiding bubbles and preventing freezing. Product-specific conditions for MSA5UM-10 should be confirmed using its own technical documentation.

Frequently Asked Questions

What is MSA5UM-10?

MSA5UM-10 is a 5µm streptavidin-functional magnetic bead suspension supplied at 1% solids for capturing biotinylated biomolecules in immunoassay research, CLIA development and batch manufacturing.

What does 1% solids mean?

When expressed as w/v, 1% solids corresponds to approximately 10mg of magnetic beads per milliliter of suspension.

Which molecules can MSA5UM-10 capture?

MSA5UM-10 can be evaluated for binding biotinylated antibodies, antigens, proteins, peptides, aptamers, DNA, RNA and other biotin-labelled molecules.

What is the binding principle?

Biotin on the selected ligand binds to streptavidin immobilized on the magnetic bead surface.

Does MSA5UM-10 require EDC or NHS activation?

No additional EDC/NHS bead activation is normally required for loading a properly biotinylated ligand.

Is a capture antibody included?

No. MSA5UM-10 is supplied as a streptavidin magnetic bead raw material. The customer selects and prepares the required biotinylated capture ligand.

Is the 1% suspension ready to use directly?

Not necessarily. The optimal working concentration depends on the ligand, target concentration, assay volume, sample matrix and analyzer.

Why choose a 5µm particle size?

The 5µm format may be evaluated when a project requires a larger micrometer-scale magnetic carrier, clearly observable collection, repeated washing or compatibility with an existing 5µm raw-material specification.

How do 5µm beads differ from 3µm beads?

Compared with 3µm particles of similar composition, 5µm particles generally provide fewer beads and less geometric surface area per unit mass, while showing different settling, magnetic collection and handling behaviour.

How do 5µm beads differ from 1µm beads?

The 1µm format generally provides more particles and more geometric surface area per unit mass. The 5µm format may provide more visible collection but requires greater attention to mixing and settling.

Do 5µm magnetic beads settle?

Micrometer-scale particles may settle during storage and incubation. The suspension should be mixed before sampling and maintained under suitable mixing during processing.

Can MSA5UM-10 be used for chemiluminescence immunoassays?

MSA5UM-10 can be evaluated as a magnetic solid phase in CLIA development. Compatibility with the complete reagent system and analyzer must be validated.

Can it be evaluated for electrochemiluminescence assays?

The product may be evaluated in ECL research. Compatibility with the electrode, magnetic positioning system, fluidics and signal chemistry must be confirmed experimentally.

Can MSA5UM-10 be used with automated analyzers?

It may be evaluated for automated systems. Dispensing, mixing, magnetic collection, aspiration, washing and redispersion must be validated on the specific analyzer.

How much biotinylated antibody should be loaded?

The optimal amount depends on the validated binding capacity, antibody molecular weight, degree of biotinylation and assay requirements. Several loading levels should be compared.

Does more antibody always improve sensitivity?

No. Excessive ligand loading may cause steric crowding, reduce target accessibility and increase nonspecific binding.

Can free biotin interfere with loading?

Yes. Free biotin can occupy streptavidin-binding sites and reduce loading of the intended biotinylated antibody, antigen or probe.

How can ligand-loading efficiency be measured?

Compare the initial ligand amount with the quantity remaining in the post-loading supernatant. Functional target-capture activity should also be measured.

Can non-biotinylated antibodies bind specifically?

Non-biotinylated antibodies are not expected to bind specifically through the streptavidin–biotin interaction. Observed binding may result from nonspecific adsorption.

How should MSA5UM-10 be mixed?

Mix using a validated method such as inversion, roller mixing, end-over-end rotation or controlled vortexing until the suspension is homogeneous.

What should be checked if magnetic collection is incomplete?

Check:

• Magnet strength;

• Collection time;

• Bead concentration;

• Buffer viscosity;

• Particle aggregation;

• Vessel geometry.

What should be checked if ligand loading is low?

Evaluate:

• Degree of biotinylation;

• Free biotin contamination;

• Ligand concentration;

• Bead quantity;

• Loading time;

• Buffer compatibility;

• Ligand aggregation.

What should be checked if assay background is high?

Evaluate:

• Blocking formulation;

• Bead dosage;

• Ligand-loading density;

• Wash efficiency;

• Sample matrix;

• Nonspecific adsorption;

• Detection-reagent concentration.

Is MSA5UM-10 a finished diagnostic reagent?

No. MSA5UM-10 is supplied as a raw material for research and reagent development. The customer is responsible for validating the finished reagent, manufacturing process and intended application.

Are evaluation samples available?

Evaluation samples can be discussed according to the intended application, biotinylated ligand and required testing quantity.

Is bulk supply available?

Pilot-scale and bulk supply can be arranged for qualified research, development and manufacturing projects.

Can the concentration, buffer or packaging be customized?

Customized solids content, streptavidin loading, suspension buffer, blocking system and packaging format may be evaluated according to project requirements.

Request a Sample or Bulk Quotation

Contact SHBC to request an evaluation sample, technical information or bulk quotation for MSA5UM-10 5µm Streptavidin Magnetic Beads.

Please provide:

• Intended immunoassay application;

• Biotinylated antibody, antigen or other ligand;

• Ligand molecular weight;

• Biotinylation method;

• Estimated degree of biotinylation;

• Required evaluation quantity;

• Estimated pilot quantity;

• Expected annual demand;

• Preferred packaging volume;

• Required technical documents;

• Required quality documents;

• Target development schedule;

• Custom specification requirements.

SHBC supports streptavidin magnetic bead projects from early ligand-loading evaluation and immunoassay optimization to pilot production and bulk manufacturing.